A large-scale study has revealed that endometriosis impacts health systems far beyond the pelvis, including cholesterol levels and the microbiome.

These findings suggest the condition is a systemic disorder rather than a localized reproductive issue. Understanding these biological mechanisms may lead to more effective treatments and earlier diagnostics for millions of patients.

The research included data from more than 1 million women [1]. Scientists found that the condition is linked to altered cholesterol levels and systemic inflammation. The study also identified changes in the microbiome, which is the community of microorganisms living in the body.

Genetic analysis played a central role in the discovery. Researchers identified specific genes associated with the condition in people of African ancestry [2]. This focus on genetic diversity helps explain why the disease may manifest differently across various populations.

By unpicking these complex biological layers, the study aims to move beyond symptom management. The researchers said the goal is to uncover the underlying mechanisms that drive the disease's progression across different organ systems.

Endometriosis has traditionally been viewed through the lens of pelvic pain and infertility. However, the evidence of systemic involvement indicates that the disease's reach is broader than previously understood. The integration of genetic and microbiome data provides a more comprehensive map of how the condition affects the entire body [2].

“Endometriosis impacts health systems far beyond the pelvis.”

This shift in understanding transforms endometriosis from a localized gynecological issue into a systemic health condition. By identifying genetic markers specific to African ancestry and linking the disease to cholesterol and inflammation, the research paves the way for personalized medicine and holistic treatment strategies that address the body's overall biological environment rather than just pelvic symptoms.